1-12 of 12
Kota Sato
Close
Sort by
Journal Articles

Real-World Clinical Outcomes in Patients with Relapse and Refractory Multiple Myeloma Received VTD-PACE Treatment in the Era of Monoclonal Antibody

Moe Yogo, Taku Kikuchi, Nobuhiro Tsukada, Kodai Kunisada, Yuki Okda, Kota Sato, Mizuki Ogura, Tomomi Takei, Yu ABE, Kenshi Suzuki, Tadao Ishida
Journal: Blood
Blood (2023) 142 (Supplement 1): 6625.
https://doi.org/10.1182/blood-2023-174725
Published: 2023
Journal Articles

Prospective Comparison Study of Prognostic Value of MRD Detected By 8-Color MFC (EuroFlow-NGF) and NGS in Patients with Multiple Myeloma in ASCT Setting

Takeshi Yoroidaka, Hiroyuki Takamatsu, Mitsuhiro Itagaki, Satoshi Yoshihara, Kota Sato, Naoki Takezako, Shuji Ozaki, Kazuhito Suzuki, Kentaro Kohno, Morio Matsumoto, Yasushi Terasaki, Takeshi Yamashita, Shin-ichi Fuchida, Ryota Urushihara, Yuji Hiragori, Kenshi Suzuki, Hirokazu Murakami, Shinji Nakao, Brian G.M. Durie, Kazuyuki Shimizu
Journal: Blood
Blood (2021) 138 (Supplement 1): 3946.
https://doi.org/10.1182/blood-2021-146441
Published: 2021
Journal Articles

Efficacy of Modified Vrd-Lite for Transplant Ineligible Multiple Myeloma

Mizuki Ogura, MDPhD, Tadao Ishida, MDPhD, Moe Nomura, Hirofumi Irita, Junichiro Nashimoto, Kota Sato, MDPhD, Kanji Miyazaki, MDPhD, Yu Abe, MD, Nobuhiro Tsukada, MDPhD, Kenshi Suzuki, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 4.
https://doi.org/10.1182/blood-2020-143459
Published: 2020
Journal Articles

The Clinical Features of Multiple Myeloma with AL Amyloidosis

Junichiro Nashimoto, Moe Nomura, Hirofumi Irita, Kota Sato, MDPhD, Kanji Miyazaki, MDPhD, Mizuki Ogura, MDPhD, Yu Abe, MD, Nobuhiro Tsukada, MDPhD, Tadao Ishida, MDPhD, Kenshi Suzuki, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 10.
https://doi.org/10.1182/blood-2020-142362
Published: 2020
Journal Articles

Combined Inhibition of HDAC and AKT As a Strategy to Overcome Multi-Drug Resistance in Patients with Multiple Myeloma

Mitsuhito Hirano, MD, Yoichi Imai, MD PhD, Takahiko Murayama, PhD, Kota Sato, MD PhD, Junichi Yamamoto, PhD, Takumi Ito, PhD, Muneyoshi Futami, MD PhD, Masaki Ri, Hiroshi Yasui, MD PhD, Noriko Gotoh, MD, Shinsuke Iida, MD PhD, Tadao Ishida, MD PhD, Hiroshi Handa, MD PhD, Arinobu Tojo, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4325.
https://doi.org/10.1182/blood-2019-122662
Published: 2019
Journal Articles

Retrospective Analysis of the Efficacy and Safety of Modified Bortezomib-Lenalidomide-Dexamethasonelite (modified RVD-lite) Therapy for Transplant Eligible Patients with Newly Diagnosed Multiple Myeloma

Kiyoshi Okazuka, MD, Tadao Ishida, MDPhD, Junichiro Nashimoto, MD, Takao Yogo, MD, Kanji Miyazaki, MD, Kota Sato, MDPhD, Yui Uto, MD PhD, Mizuki Ogura, MDPhD, Yumiko Yoshiki, MDPhD, Yu ABE, MD, Nobuhiro Tsukada, MDPhD, Kenshi Suzuki, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1961.
https://doi.org/10.1182/blood-2018-99-112294
Published: 2018
Journal Articles

Histone Deacetylase Inhibitors with or without AKT Inhibition Potentially Increase the Efficacy of Daratumumab in Multiple Myeloma By Enhancing the Antibody-Dependent Cell-Mediated and Complement-Dependent Cytotoxicity As Well As Apoptosis

Mitsuhito Hirano, MD, Yoichi Imai, MD PhD, Weng-Chit Ung, MSc, Kota Sato, MD PhD, Muneyoshi Futami, MD PhD, Arinobu Tojo, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4435.
https://doi.org/10.1182/blood-2018-99-110709
Published: 2018
Journal Articles

Evaluation of Oncolytic Viral Therapy Combined with or without Artificial Immunoadjuvant Cell Therapy in Immunocompetent Mouse Tumor Models

Weng-Chit Ung, MSc, Muneyoshi Futami, MD PhD, Kota Sato, MDPhD, Arinobu Tojo, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5793.
https://doi.org/10.1182/blood-2018-99-112789
Published: 2018
Journal Articles

Retrospective Analysis of High-Dose Melphalan and Autologous Stem Cell Transplantation for Systemic Light-Chain Amyloidosis: A Single Center 63 Cases

Kiyoshi Okazuka, MD, Nobuhiro Tsukada, Kota Sato, MD, Kanji Miyazaki, Yumiko Yoshiki, Yu Abe, MD, Tadao Ishida, MD, Kenshi Suzuki
Journal: Blood
Blood (2017) 130 (Supplement 1): 4542.
https://doi.org/10.1182/blood.V130.Suppl_1.4542.4542
Published: 2017
Journal Articles

Feasibility of a Cell-Based Oncolytic Virotherapy Targeting Bone Marrow Lesions of Multiple Myeloma

Kota Sato, MD, Muneyoshi Futami, MD PhD, Ung Weng Chit, Takafumi Nakamura, MD PhD, Arinobu Tojo, MD PhD
Journal: Blood
Blood (2016) 128 (22): 4499.
https://doi.org/10.1182/blood.V128.22.4499.4499
Published: 2016
Journal Articles

Thymidine Kinase-Deleted, let7a-Regulated Vaccinia Virus Specifically Infects and Lyses Myeloma Cells in a Mouse Myeloma Model

Muneyoshi Futami, MDPhD, Kota Sato, MD, Takafumi Nakamura, PhD, Arinobu Tojo, MD PhD
Journal: Blood
Blood (2014) 124 (21): 2082.
https://doi.org/10.1182/blood.V124.21.2082.2082
Published: 2014
Journal Articles

DC-HIL is a negative regulator of T lymphocyte activation

Jin-Sung Chung, Kota Sato, Irene I. Dougherty, Ponciano D. Cruz, Jr, Kiyoshi Ariizumi
Journal: Blood
Blood (2007) 109 (10): 4320–4327.
https://doi.org/10.1182/blood-2006-11-053769
Published: 2007
Includes: Supplemental data